Treace Medical Concepts (TMCI) Cash from Financing Activities (2020 - 2026)
Treace Medical Concepts posted quarterly Cash from Financing Activities of -$588000.0 for Q1 2026, down 108.51% year-on-year from $6.9 million in Q1 2025, and down 142.55% on a QoQ basis from $1.4 million in Q4 2025.
Treace Medical Concepts (TMCI) has 7 years of Cash from Financing Activities data on file, last reported at -$588000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 108.51% year-over-year to -$588000.0; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (up 2711.11% YoY), and the FY2025 full-year result was $2.1 million, up 1198.12% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$588000.0, down from $1.4 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $107.9 million in Q1 2023 and bottomed at -$588000.0 in Q1 2026.
- The 5-year median for Cash from Financing Activities is $297000.0 (2022), against an average of $7.8 million.
- The widest annual swing landed in 2023, when Cash from Financing Activities soared 7762.9%; it then slumped 225.0% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at $297000.0 in 2022, then plunged by 44.44% to $165000.0 in 2023, then tumbled by 84.24% to $26000.0 in 2024, then soared by 5215.38% to $1.4 million in 2025, then sank by 142.55% to -$588000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$588000.0 (Q1 2026), $1.4 million (Q4 2025), and -$10000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Treace Medical Concepts | 234.79 Mn | 182.94 Mn | 37.41 Mn | -588,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -588,000.00 |
| Mar 31, 2026 | -588,000.00 |
| Dec 31, 2025 | 1.38 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | -10,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | 987,000.00 |
| Jun 30, 2025 | 987,000.00 |
| Mar 31, 2025 | -282,000.00 |
| Mar 31, 2025 | -282,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 311,000.00 |
| Jun 30, 2024 | 311,000.00 |
| Mar 31, 2024 | -185,000.00 |
| Mar 31, 2024 | -185,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Sep 30, 2023 | 159,000.00 |
| Sep 30, 2023 | 159,000.00 |
| Jun 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 107.88 Mn |
| Mar 31, 2023 | 107.88 Mn |
| Dec 31, 2022 | 297,000.00 |
| Dec 31, 2022 | 297,000.00 |
| Sep 30, 2022 | 353,000.00 |
| Sep 30, 2022 | 353,000.00 |
| Jun 30, 2022 | 18.78 Mn |
| Jun 30, 2022 | 18.78 Mn |
| Mar 31, 2022 | 1.37 Mn |
| Mar 31, 2022 | 1.37 Mn |
| Dec 31, 2021 | 1.03 Mn |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 41,000.00 |
| Sep 30, 2021 | 41,000.00 |
| Jun 30, 2021 | 107.80 Mn |
| Jun 30, 2021 | 107.80 Mn |
| Mar 31, 2021 | -1.22 Mn |
| Mar 31, 2021 | -1.22 Mn |
| Dec 31, 2020 | 323,000.00 |
| Dec 31, 2020 | 323,000.00 |
| Sep 30, 2020 | 9.35 Mn |
| Sep 30, 2020 | 9.35 Mn |
| Jun 30, 2020 | 1.80 Mn |
| Jun 30, 2020 | 1.80 Mn |
| Mar 31, 2020 | 33,000.00 |
| Mar 31, 2020 | 33,000.00 |